Milam S B, Giovannitti J A
Dent Clin North Am. 1984 Jul;28(3):493-508.
Local anesthetics are the most widely used drugs in dentistry today. Knowledge of the pharmacology and toxicology of these agents will result in their intelligent and judicious use. The choice of local anesthetic should be individualized for each patient. The duration of the dental procedure should be weighed against the duration of action of the local anesthetic; a decision should be made as to whether a vasoconstrictor is needed to prolong its action. However, if the duration of numbness is too long, the possibility of self-mutilation must be considered in certain patients (for example, children and the mentally retarded). In other patients with whom postoperative pain is expected, it may be beneficial to administer a long-acting local anesthetic such as bupivacaine for control of postoperative pain. The total dose of local anesthetic and vasoconstrictor must be determined for each patient based upon body weight; the maximal dosages for each agent should be known. Small children or frail individuals will require below average dosages. The use of a vasoconstrictor may constitute the limiting factor to the total number of local anesthetic cartridges that can be administered safely over a given period of time. Certain medical problems, such as cardiovascular system impairments or hyperthyroidism, may influence the choice of anesthetic and the quantity of vasoconstrictor. An understanding of the physicochemical properties of local anesthetics is also important to a rational process of selection. There are several causes for failure to achieve profound regional anesthesia. These include inflammation and/or infection, anatomic variation, intravascular injection, accessory innervation, and deflection of the needle. Inflammation and infection reduce the efficacy of a local anesthetic by reducing its bioavailability. Local anesthetics with low pKa values (for instance, mepivacaine) are the most effective in this clinical situation. Other causes of inadequate regional anesthesia are primarily related to technique of administration and can be circumvented by the use of the periodontal ligament injection. A comprehensive review of this technique and its application has been presented by the Council on Dental Materials and Equipment of the American Dental Association. Occasionally, a clinician may be unsuccessful at achieving regional anesthesia despite these additional measures. Highly anxious dental patients or patients with a genuine tolerance to local anesthetics normally pose the most problems. Transitional block or threshold block phenomena should also be suspected in these situations.(ABSTRACT TRUNCATED AT 400 WORDS)
局部麻醉药是当今牙科领域应用最为广泛的药物。了解这些药物的药理学和毒理学知识有助于合理明智地使用它们。局部麻醉药的选择应因人而异。应根据牙科手术的时长来权衡局部麻醉药的作用时长;还应决定是否需要使用血管收缩剂来延长其作用时间。然而,如果麻木持续时间过长,对于某些患者(如儿童和智障患者),必须考虑自残的可能性。对于预计术后会疼痛的其他患者,使用长效局部麻醉药(如布比卡因)来控制术后疼痛可能有益。必须根据体重为每位患者确定局部麻醉药和血管收缩剂的总剂量;应了解每种药物的最大剂量。小儿或体弱者所需剂量低于平均水平。使用血管收缩剂可能会限制在给定时间段内安全使用的局部麻醉药 cartridges 的总数。某些医疗问题,如心血管系统损伤或甲状腺功能亢进,可能会影响麻醉药的选择和血管收缩剂的用量。了解局部麻醉药的物理化学性质对于合理的选择过程也很重要。未能实现深度区域麻醉有多种原因。这些原因包括炎症和/或感染、解剖变异、血管内注射、副神经支配以及针头偏斜。炎症和感染会降低局部麻醉药的生物利用度,从而降低其疗效。在这种临床情况下,pKa 值较低的局部麻醉药(如甲哌卡因)最为有效。区域麻醉不足的其他原因主要与给药技术有关,使用牙周膜注射可避免这些问题。美国牙科协会牙科材料与设备委员会已对该技术及其应用进行了全面综述。偶尔,尽管采取了这些额外措施,临床医生仍可能无法实现区域麻醉。高度焦虑的牙科患者或对局部麻醉药真正耐受的患者通常问题最大。在这些情况下,还应怀疑过渡性阻滞或阈值阻滞现象。(摘要截取自 400 字)